SHIFT Newsroom · GLOBAL
Tirzepatide and heart rhythm: rare-event analysis needs cautious interpretation
A meta-analysis in the Journal of the American Heart Association did not find a clear association with atrial fibrillation or atrial arrhythmia; the uncertainty intervals included no difference.
A meta-analysis in the Journal of the American Heart Association did not find a clear association with atrial fibrillation or atrial arrhythmia; the uncertainty intervals included no difference. A broader outcome covering any arrhythmia showed higher odds, but events were uncommon and estimates require caution. These distinct outcomes should not be merged into a claim that tirzepatide causes atrial fibrillation or that all rhythm risks have been excluded.
SHIFT’s take
Read the study design and limits alongside the finding. This article does not determine individual treatment suitability.